XTX Topco’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $405K | Sell |
7,332
-6,925
| -49% | -$383K | 0.02% | 1245 |
|
|
2025
Q1 | $689K | Buy |
14,257
+7,513
| +111% | +$363K | 0.04% | 790 |
|
|
2024
Q4 | $260K | Sell |
6,744
-8,057
| -54% | -$311K | 0.02% | 1329 |
|
|
2024
Q3 | $666K | Buy |
+14,801
| New | +$666K | 0.05% | 626 |
|
|
2023
Q4 | – | Sell |
-16,139
| Closed | -$269K | – | 2022 |
|
|
2023
Q3 | $269K | Buy |
+16,139
| New | +$269K | 0.05% | 807 |
|
|
2023
Q1 | – | Sell |
-12,942
| Closed | -$141K | – | 1587 |
|
|
2022
Q4 | $141K | Sell |
12,942
-25,882
| -67% | -$282K | 0.03% | 938 |
|
|
2022
Q3 | $327K | Buy |
38,824
+26,201
| +208% | +$221K | 0.08% | 459 |
|
|
2022
Q2 | $100K | Buy |
+12,623
| New | +$100K | 0.04% | 645 |
|